Literature DB >> 4043011

Relative bioavailability of rectally administered carbamazepine suspension in humans.

N M Graves, R L Kriel, C Jones-Saete, J C Cloyd.   

Abstract

The relative bioavailability of an investigational carbamazepine suspension was studied following rectal administration in human volunteers. Carbamazepine, in doses of approximately 6 mg/kg, was given to nine men. The routes of administration were oral tablet, oral suspension, and rectal suspension. There was no significant difference (p greater than 0.05) in total absorption, maximum serum concentration, and time to achieve maximum serum concentration between the orally-administered tablet and the rectally administered suspension. Orally administered suspension was absorbed more quickly and completely. All volunteers complained of a strong defecatory urge after the suspension was given rectally. The slow absorption after rectal administration precludes the use of this route in status epilepticus; however, it may be a satisfactory alternative for maintenance therapy when administration by the oral route is not possible.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4043011     DOI: 10.1111/j.1528-1157.1985.tb05675.x

Source DB:  PubMed          Journal:  Epilepsia        ISSN: 0013-9580            Impact factor:   5.864


  10 in total

Review 1.  Pharmacokinetics of rectal drug administration, Part II. Clinical applications of peripherally acting drugs, and conclusions.

Authors:  E J van Hoogdalem; A G de Boer; D D Breimer
Journal:  Clin Pharmacokinet       Date:  1991-08       Impact factor: 6.447

Review 2.  Perioperative substitution of anti-epileptic drugs.

Authors:  Wilma S W Wichards; Alfred F A M Schobben; Frans S S Leijten
Journal:  J Neurol       Date:  2013-09-01       Impact factor: 4.849

3.  Development of carbamazepine transnasal microemulsion for treatment of epilepsy.

Authors:  Sheetal Porecha Acharya; K Pundarikakshudu; Ashish Panchal; Anita Lalwani
Journal:  Drug Deliv Transl Res       Date:  2013-06       Impact factor: 4.617

4.  Relative bioavailability, metabolism and tolerability of rectally administered oxcarbazepine suspension.

Authors:  Pamela L Clemens; James C Cloyd; Robert L Kriel; Rory P Remmel
Journal:  Clin Drug Investig       Date:  2007       Impact factor: 2.859

5.  Absorption and safety of rectally administered phenytoin.

Authors:  R H Fuerst; N M Graves; R L Kriel; R Olson
Journal:  Eur J Drug Metab Pharmacokinet       Date:  1988 Oct-Dec       Impact factor: 2.441

6.  Absorptive clearance of carbamazepine and selected metabolites in rabbit intestine.

Authors:  L E Riad; R J Sawchuk
Journal:  Pharm Res       Date:  1991-08       Impact factor: 4.200

Review 7.  Treatment of epilepsy in women of reproductive age: pharmacokinetic considerations.

Authors:  James W McAuley; Gail D Anderson
Journal:  Clin Pharmacokinet       Date:  2002       Impact factor: 6.447

8.  Relationship between systemic drug absorption and gastrointestinal transit after the simultaneous oral administration of carbamazepine as a controlled-release system and as a suspension of 15N-labelled drug to healthy volunteers.

Authors:  I R Wilding; S S Davis; J G Hardy; C S Robertson; V A John; M L Powell; M Leal; P Lloyd; S M Walker
Journal:  Br J Clin Pharmacol       Date:  1991-11       Impact factor: 4.335

9.  Investigating Oral Absorption of Carbamazepine in Pediatric Populations.

Authors:  Philip Kohlmann; Cordula Stillhart; Martin Kuentz; Neil Parrott
Journal:  AAPS J       Date:  2017-10-02       Impact factor: 4.009

Review 10.  Antiepileptic drugs in the treatment of neuropathic pain.

Authors:  Elon Eisenberg; Yaron River; Ala Shifrin; Norberto Krivoy
Journal:  Drugs       Date:  2007       Impact factor: 9.546

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.